Lam Research (NASDAQ:LRCX) Trading Up 3.4% – Here’s Why

Shares of Lam Research Corporation (NASDAQ:LRCX) rose 3.4% on Monday . The company traded as high as $221.46 and last traded at $219.40. Approximately 9,504,108 shares changed hands during mid-day trading, a decline of 21% from the average daily volume of 12,045,597 shares. The stock had previously closed at $212.20.

Wall Street Analyst Weigh In

Several research analysts have commented on LRCX shares. JPMorgan Chase & Co. upped their target price on shares of Lam Research from $165.00 to $300.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Lam Research in a report on Monday, December 29th. The Goldman Sachs Group set a $262.00 price target on Lam Research and gave the stock a “buy” rating in a research note on Thursday, January 29th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $290.00 price objective (up from $260.00) on shares of Lam Research in a report on Thursday, January 29th. Finally, Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $245.35.

Lam Research Trading Up 3.4%

The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. The firm has a market cap of $273.98 billion, a price-to-earnings ratio of 44.96, a PEG ratio of 2.28 and a beta of 1.77. The company has a 50-day moving average price of $224.75 and a 200 day moving average price of $173.67.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the business earned $0.91 EPS. The business’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be given a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is 21.31%.

Insider Buying and Selling

In related news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at approximately $57,235,848. This represents a 12.12% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 130,886 shares of company stock worth $29,658,802. 0.31% of the stock is owned by company insiders.

Institutional Trading of Lam Research

Several hedge funds and other institutional investors have recently modified their holdings of LRCX. PMV Capital Advisers LLC acquired a new position in Lam Research in the 4th quarter worth about $25,000. Stance Capital LLC acquired a new stake in shares of Lam Research during the 3rd quarter valued at about $26,000. Bayban bought a new stake in shares of Lam Research in the 4th quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new position in Lam Research in the second quarter worth approximately $27,000. Finally, Triumph Capital Management acquired a new position in Lam Research in the third quarter worth approximately $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.